Syndrome douloureux mammaire : recommandations

Ngô, Charlotte; Séror, J; Chabbert-Buffet, Nathalie

doi:10.1016/j.jgyn.2015.09.039

Cited by 7 publications

(2 citation statements)

References 55 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, these studies did not report if other measures, such as reassurance, dietary modification and external breast support, were used along with Ormeloxifene. This information is crucial, as various studies have reported that reassurance and dietary modifications are effective in 50%-90% of mastalgia patients (13)(14)(15). A similar outcome was observed with the placebo and GLA arms in our study compared to the Ormeloxifene arm, but it should be noted that all patients were advised to modify diet and seek breast support while all patients received reassurance at all visits.…”

Section: Discussionsupporting

confidence: 81%

Open-Label Three Arm Trial Comparing Ormeloxifene, Gamma Linolenic Acid With Methylcobalamine + Vitamin C and Placebo in Mastalgia

Verma¹,

Sharma²,

Yadav³

et al. 2022

EJBH

View full text Add to dashboard Cite

Points• Centchroman, also known as Ormeloxifene, is a relatively new drug under the class of non-steroidal selective estrogen receptor modulators which is being used to treat mastalgia. •We evaluated the beneficial effect of Ormeloxifene (Centchroman) versus a combination of Gamma Linolenic acid (GLA), methylcobalamine and vitamin C on mastalgia in a three-arm, open-label, placebo-controlled trial.• In this study Ormeloxifene was not superior to GLA or placebo and was also associated with concerning side effects.

show abstract

Section: Discussionsupporting

confidence: 81%

Open-Label Three Arm Trial Comparing Ormeloxifene, Gamma Linolenic Acid With Methylcobalamine + Vitamin C and Placebo in Mastalgia

Verma¹,

Sharma²,

Yadav³

et al. 2022

EJBH

View full text Add to dashboard Cite

show abstract

“…Мастодиния -наиболее частый симптом заболевания, встречается в 45-70% случаев [6,29,30]. В нашей группе все женщины предъявляли жалобы на боли в молочных железах.…”

Section: результаты и обсуждениеunclassified

Dispensary group of women with benign diseases of the mammary glands: a school of prevention, observation, examination, treatment

Sukhareva

Somov

2023

Medicinskij sovet

View full text Add to dashboard Cite

Introduction. The issues of dispensary check-ups for women with benign breast diseases (BBD) still remain an urgent challenge. What stands out are delayed visits to the doctor, irregular examinations and failure to follow prescribed therapy. Women’s health schools equipped with state-of-the -art information and communication technologies contribute to improving motivation for regular check-ups, timely examinations and adherence to treatment.Aim. To study the impact of training on adherence to regular visits, examination and treatment provided to a dispensary group of women with BBD at the Prevention School.Materials and methods. A total of 486 women with BBD who attended the Women’s Health Prevention School were observed. A professional medical advice included a gynaecological screening and consultation with an oncologist, breast ultrasound imaging for women of all age groups and mammography for women aged 40 years and older; once diffuse benign changes to breast tissues were detected, the women were prescribed Mastodynon (Bionorica SE) for 3 months.Results. After training, the rates of visits to a doctor increased from 69.3% to 94.2%, the examination rates increased from 66.8% to 88.6%, adherence to regular therapy increased from 43.6% to 82.9%. 82.9% of women reported health improvements after therapy with the herbal medicine, 7.6% – absence of changes, 4.3% – deterioration in the condition, of which 2.6% – menstrual disorders, 5.2% women discontinued therapy (due to poor tolerance – 3.6%, skin reactions – 1.0%, family reasons – 0.6%).Conclusion. Raising women’s awareness about breast cancer and a set of measures increase the early detection of breast diseases and women’s cancer alertness.

show abstract

Recommandations pour la pratique clinique : tumeurs bénignes du sein – Objectifs, méthodes et organisation

Lavoué

Fritel

Chopier

et al. 2015

Journal de Gynécologie Obstétrique et Biologie de la Reproducti

View full text Add to dashboard Cite

Syndrome douloureux mammaire : recommandations

Cited by 7 publications

References 55 publications

Open-Label Three Arm Trial Comparing Ormeloxifene, Gamma Linolenic Acid With Methylcobalamine + Vitamin C and Placebo in Mastalgia

Open-Label Three Arm Trial Comparing Ormeloxifene, Gamma Linolenic Acid With Methylcobalamine + Vitamin C and Placebo in Mastalgia

Dispensary group of women with benign diseases of the mammary glands: a school of prevention, observation, examination, treatment

Recommandations pour la pratique clinique : tumeurs bénignes du sein – Objectifs, méthodes et organisation

Contact Info

Product

Resources

About